Carolina Cimminiello

Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma

Alice Indini, Lorenza Di Guardo, Carolina Cimminiello et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 193 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Improved Survival +10

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

Paolo A. Ascierto, Ester Simeone, Vanna Chiarion‐Sileni et al. · Journal of Translational Medicine · 2014 · 162 citations · Full text

Sequential Treatment with Ipilimumab and BRAF Inhibitors in Patients With Metastatic Melanoma: Data From the Italian Cohort of the Ipilimumab Expanded Access Program

Paolo A. Ascierto, Ester Simeone, Vanna Chiarion‐Sileni et al. · Cancer Investigation · 2014 · 104 citations

Oncology, Skin Cancer, Melanoma +13

The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy

Giovanni Fucà, Teresa Beninato, Marta Bini et al. · Targeted Oncology · 2021 · 58 citations

Inflammation, Pan-immune-inflammation Value, Cancer Immunosurveillance +11

Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience

Alice Indini, Lorenza Di Guardo, Carolina Cimminiello et al. · Journal of Gynecologic Oncology · 2019 · 57 citations · Full text